Paige.AI

FDA grants 'Breakthrough Device' designation to technologies that have the potential to provide more effective diagnosis

Computational pathology startup Paige.AI gets ‘Breakthrough Designation’ from FDA

The computational pathology startup Paige.AI has received 'Breakthrough Device' designation by the U.S. Food and Drug Administration (FDA)
Healthcare startup Paige.AI ropes in Leo Grady as CEO

Healthcare startup Paige.AI ropes in Leo Grady as CEO

Paige.AI was launched in 2018 based on technology developed by its Co-Founder and Chief Scientific Officer, Dr. Thomas Fuchs, and a license agreement with Memorial Sloan Kettering Cancer Center (MSK).
- Advertisement -SAP Hana